DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ravuconazole
Ravuconazole
Discovery of Anti-Amoebic Inhibitors from Screening the MMV Pandemic Response Box on Balamuthia Mandrillaris, Naegleria Fowleri
Integrated Molecular Profiling for Analyzing and Predicting Therapeutic Mechanism, Response, Biomarker and Target
1,4-Disubstituted-1,2,3-Triazole Compounds Induce Ultrastructural Alterations in Leishmania Amazonensis Promastigote
Conazoles
Review Article Sporotrichosis: an Overview and Therapeutic Options
2011/058582 Al O
Abstract #15 Drug Repurposing for Human Visceral Leishmaniasis: Screening Marketed Antifungal Azoles for Inhibition of Leishmani
Novel Insights Into P450 BM3 Interactions with FDA-Approved Antifungal Azole Drugs Received: 1 August 2018 Laura N
Antifungal Reference Materials
New-Generation Triazole Antifungal Drugs: Review of the Phase II and III Trials
Treatment of Vaginitis Caused by Candida Glabrata: Use of Topical Boric Acid and Flucytosine
Discovery of Anti-Amoebic Inhibitors from Screening the MMV Pandemic Response Box on Balamuthia Mandrillaris, Naegleria Fowleri, and Acanthamoeba Castellanii
Stembook 2018.Pdf
Sun Georgetown 0076D 12242.Pdf (4.4MB)
Translational Biology (TB)
Analysis of Imidazoles and Triazoles in Biological Samples After Microextraction by Packed Sorbent
Therapy of Skin, Hair and Nail Fungal Infections
Antifungals of the Azole Type
Top View
Or 6-Methyl-2-Substituted Benzoxazoles/Benzimidazoles
223 © Springer International Publishing Switzerland 2017 A. Tosti Et Al. (Eds.), Onychomycosis, DOI 10.1007/978-3-319-44853-4
WO 2012/177986 A2 27 December 2012 (27.12.2012) P O P C T
Review on Antimicrobial Agents
Functional Characterization of Hos2 Candida Albicans Histone
New and Investigational Triazole Agents for the Treatment of Invasive Fungal Infections REVIEW
Onychomycosis/Fungal Apr10
Terpene Extract for the Treatment of Hair Loss Terpenextrakt Zur Behandlung Von Haarausfall Extrait De Terpène Pour Le Traitement De La Perte Des Cheveux
207500Orig1s000 / 207501Orig1s000
Identification and in Vitro Antifungal Susceptibility of Causative Agents Of
Anti-Trypanosomatid Drug Discovery: an Ongoing Challenge and a Continuing Need
Download Available)
Infoleish Redeleish Newsletter 3Rd Edition
Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma Cruzi Strain in Mice
Article 14.Indd
Early State Research on Antifungal Natural Products
In Vitro Activity of Ravuconazole Against Zygomycetes, Scedosporium and Fusarium Spp
Candida Species
Antifungal Agents Spectrum of Activity, Pharmacology, and Clinical Indications
Dedicated to My Parents, Augustine and Rosemary Nti-Addae
US 2007/0054844 A1 Lane (43) Pub
Epoxide Syntheses and Ring-Opening Reactions in Drug Development
Antifungal Drugs • Antifungal Susceptibility Testing • Resistance to Antifungal Drugs
In Vitro Antileishmanial Activity of Ravuconazole, a Triazole Antifungal Drug, As a Potential Treatment for Leishmaniasis
Journal of Pharmaceutics and Nanotechnology
Isavuconazole Pharmacodynamic Target Determination for Candida Species in an in Vivo 1 Murine Disseminated Candidiasis Model
Evaluation of in Vitro Antileishmanial Efficacy of Cyclosporin a and Its Non
M-1797 Can Half
Antimicrobial Agents